Peak Pharmaceuticals, Inc. (OTCMKTS:PKPH – Get Free Report) shares dropped 55.7% during trading on Monday . The stock traded as low as $2.70 and last traded at $3.00. Approximately 3,378 shares were traded during trading, a decline of 63% from the average daily volume of 9,053 shares. The stock had previously closed at $6.77.
Peak Pharmaceuticals Stock Performance
The company has a fifty day simple moving average of $3.68 and a 200 day simple moving average of $2.32.
Peak Pharmaceuticals Company Profile
Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.
Featured Articles
- Five stocks we like better than Peak Pharmaceuticals
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Alphabet’s Officially In A Bear Market—Time To Buy?
- Earnings Per Share Calculator: How to Calculate EPS
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
